Biomarkers are biological characteristics that can be used to indicate health or disease. This
paper reviews studies on biomarkers of low back pain (LBP) in human subjects. LBP is the …

Advanced methods for manufacturing high quality parts should be used to ensure the
production of competitive products for the world market. Investment casting (IC) is a process …

Background Many intervertebral disc diseases cause low back pain (LBP). Proinflammatory
cytokines and matrix metalloproteinases (MMPs) participate in disc pathology. In this study …

Background: The pathogenesis of low back pain (LBP) remains unclear. However, recent
studies suggest that the inflammatory response may be inherent in spinal pain. The purpose …

Spinal conditions related to intervertebral disc (IVD) degeneration cost billions of dollars in
the US annually. Despite the prevalence and soaring cost, there is no specific treatment that …

Low back pain (LBP) is a widespread debilitating disorder of significant socio-economic
importance and intervertebral disc (IVD) degeneration has been implicated in its …

Low back pain (LBP) management is an important clinical issue. Inadequate LBP control
has consequences on the mental and physical health of patients. Thus, acquiring new …

Background: Lumbar traction therapy is a common method to reduce low back pain (LBP)
but is not always effective. The search for biomarkers that would prognose the effectiveness …

Objective The contributions of intervertebral disc disease and subject-specific covariates to
systemic inflammation in low back pain are unknown. We examined the effects of …

Low back pain which is a major cause of disability for people aged between 20 and 50 years
imposes a serious socio-economic burden. The current focus of regenerative medicine is on …